title: Coronary drug-eluting stent development: issues in trial design.
authors.affiliation: Center for Devices and Radiological Health, U.S. Food and Drug Administration, Rockville, Md 20850, USA. neal.muni@fda.hhs.gov
authors.forename: Neal I
authors.initials: NI
authors.lastname: Muni
authors.forename: Robert M
authors.initials: RM
authors.lastname: Califf
authors.forename: Jonette R
authors.initials: JR
authors.lastname: Foy
authors.forename: Ashley B
authors.initials: AB
authors.lastname: Boam
authors.forename: Bram D
authors.initials: BD
authors.lastname: Zuckerman
authors.forename: Richard E
authors.initials: RE
authors.lastname: Kuntz
mesh_terms: D000818:Animals; D002986:Clinical Trials as Topic / Q000379:methods*; D023903:Coronary Restenosis / Q000175:diagnosis / Q000209:etiology; D023921:Coronary Stenosis / Q000628:therapy; D016503:Drug Delivery Systems / Q000379:methods*; D004867:Equipment Design; D006801:Humans; D020714:Maximum Tolerated Dose; D023421:Models, Animal; D010599:Pharmacokinetics; D011358:Product Surveillance, Postmarketing / Q000379:methods*; D012008:Recurrence; D012107:Research Design; D015607:Stents / Q000009:adverse effects